Terri Parker, MD
Assistant Professor of Medicine (Hematology); Assistant Professor
Patient Care
Accepts new patients? Yes
Patient Type: Adult
Referrals: Not Applicable
Patient Care Organizations
Board Certifications
-
Internal Medicine AB of Internal Medicine (2008)
-
Hospice & Palliative Medicine AB of Internal Medicine (2010)
-
Hematology (Internal Medicine) AB of Internal Medicine (2012)
-
Medical Oncology AB of Internal Medicine (2013)
Clinical Trials
| Conditions | Study Title |
|---|---|
| Multiple Myeloma | Safety Study of SGN-CD48A in Patients With Multiple Myeloma |
| Non-Hodgkin's Lymphoma | A Phase I, Open-Label, Dose Finding Study of CC-90002, a Monoclonal Antibody Directed Against CD47, in Subjects With Advanced Solid and Hematologic Cancers |
| Leukemia, not otherwise specified, Myeloid and Monocytic Leukemia | A Phase 1/2 Study of INCB053914 in Subjects With Advanced Malignancies |
| Multiple Myeloma | Randomized Phase III Trial of Bortezomib, Lenalidomide and Dexamethasone (VRd) Versus Carfilzomib, Lenalidomide, Dexamethasone (CRd) Followed by Limited or Indefinite Lenalidomide Maintenance in Patients With Newly Diagnosed Symptomatic Multiple Myeloma |
